Core Laboratories N.V.

NYSE: CLB · Real-Time Price · USD
10.41
-0.19 (-1.79%)
At close: Aug 15, 2025, 3:59 PM
10.44
0.24%
After-hours: Aug 15, 2025, 05:16 PM EDT

Core Laboratories Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
10.67M 69K 7.47M 11.74M 9.03M 3.22M 2.2M 9.26M 22.85M 2.44M 6.69M 7.65M 7.16M -1.84M 2.79M 1.01M 8.22M 8.21M
Depreciation & Amortization
3.67M 3.72M 3.66M 3.68M 3.77M 3.84M 3.87M 3.93M 3.94M 4.04M 4.07M 4.17M 4.36M 4.56M 4.4M 4.5M 4.75M 4.87M
Stock-Based Compensation
538K 4.16M -458K -1.9M -132K 4.82M 1.56M 2.07M 1.35M 8.98M 304K 2.23M -1.01M 6.23M 2.45M 8.56M 3.68M 4.41M
Other Working Capital
-1.41M 1.4M -204K 608K 5.23M -4.03M 11.95M -8.52M -2.13M -1.6M -2.74M -1.5M 665.92K -6.02M 10.65M -5.07M 3.45M 407K
Other Non-Cash Items
-2.41M 2.37M -324K -384.89K -911.7K 703K -1.9M -1.4M 8.62M -1.35M 1.18M -1.55M -6.4M -3.72M -4K 638K -3.51M -12.88M
Deferred Income Tax
-1.35M -1.82M 572K 875.89K -3.6M 2.83M 3.95M n/a -11.96M 936K 2.24M -2.34M -1.17M 1.7M 2.95M 326K -1.97M 4.7M
Change in Working Capital
2.8M -1.84M 9.69M -915K 8.99M -9.88M 9.74M -14.07M -4.46M -18.23M -1.27M -4.32M -2.33M -1.64M -5.43M -3.08M -1.68M -1.31M
Operating Cash Flow
13.92M 6.66M 20.61M 13.1M 17.15M 5.53M 19.43M -215.93K 8.78M -3.17M 13.21M 5.85M 605K 5.29M 7.15M 11.95M 9.49M 7.99M
Capital Expenditures
n/a -3.58M -4.38M -2.73M -2.84M -3.06M -2.63M -3.48M -2.21M -2.21M -2.02M -2.7M -3.2M -2.3M -4.75M -3.13M -2.88M -2.77M
Cash Acquisitions
n/a n/a n/a n/a 204.8K 593K 59.62K 67.29K 185.53K 170K 2.07M -507.63K 426.63K 81K 360K -284.63K 513K n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -2.07M n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -583K n/a n/a 583K n/a n/a n/a n/a
Other Investing Acitivies
-1.64M 772K 822K 2.26M 1.96M 805K 72.38K -1.52K 3.4M 80K 3.66M 652.63K -15.63K 2.14M 696K -19K 64K 1.7M
Investing Cash Flow
-1.64M 772K -3.56M -491K -677.63K -1.66M -2.45M -3.41M 1.21M -2.04M 1.06M -2.56M -2.79M 428K -3.69M -3.15M -2.31M -1.07M
Debt Repayment
-77.17K -2M -14M -8M -13M -3M -16.24M -4.03M 2M 8M -10M -3M -3M 1M n/a -20M n/a -51M
Common Stock Repurchased
-2.92M -2.02M -4.9M -196K -162K -44K -1.78M -218K -199K -1K -1.59M -145K -246K -1.92M -4.34M -2.88M -860K -171K
Dividend Paid
-505.19K -469K -469K -469K -466.25K -468K -447.74K -469.72K -474.7K -466K -489.74K -406.5K -463K -463K -462K -463K -463K -446K
Other Financial Acitivies
307.06K 9K n/a -162K -48.75K -568K 1.16M -1.02M -87.25K -1.47M -517K -1.79M n/a -1K n/a -25K -44K -1.3M
Financial Cash Flow
-3.2M -4.48M -19.37M -8.83M -13.68M -4.08M -18.48M -6.03M 1.21K 6.06M -12.57M -5.71M -3.71M -1.38M -4.81M -23.37M -1.37M 7.08M
Net Cash Flow
9.08M 2.95M -2.32M 3.78M 2.78M -207K -1.5M -9.59M 9.92M 857K 1.7M -2.42M -5.89M 4.33M -1.35M -14.57M 5.81M 14M
Free Cash Flow
13.92M 3.08M 16.23M 10.37M 14.21M 2.48M 16.63M -3.69M 6.58M -5.38M 11.19M 3.15M -2.59M 2.99M 2.4M 8.82M 6.6M 5.21M